x
Marksman Healthcare
[contact-form-7 id="2459" title="Sidebar Form"]

  • Bulls Stadium, California
  • 666-888-0000
  • info@example.com
Marksman Healthcare
  • Home
  • About Us
  • Services
    • HEOR
    • RWE
    • Value Communications
    • Competitive Intelligence
  • Case studies
  • Publications
  • Key Highlights
  • Blog
  • MarksMan Academy
  • Contact Us
Marksman Healthcare
  • Contact Us
Logo

Contact Info

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • +91-9160467576
  • enquiry@marksmanhealthcare.com

Author: MarksMan Healthcare

    Marksman Healthcare > Articles by: MarksMan Healthcare
The banner image talks about evaluation of medical devices using RCT and RWD

12Jul

Evaluating Medical Devices: How Do RCT Data and RWD Fit Together?

by MarksMan Healthcare,  0 Comments

Medical devices play a critical role in modern healthcare, aiding in diagnosing, treating, and managing various diseases and conditions. Before these devices are approved for widespread use, they undergo rigorous […]

Read More
The image mentions "Challenges in the Use of Real-World Evidence for Pharmacoeconomic Modeling" which is the topic of the blog

06Jul

Challenges in the Use of Real-World Evidence for Pharmacoeconomic Modeling

by MarksMan Healthcare,  0 Comments

Pharmacoeconomic modeling is vital for healthcare decision-making, enabling stakeholders to evaluate the value and cost-effectiveness of pharmaceutical interventions. These models offer insights into clinical and economic outcomes, aiding policymakers, providers, […]

Read More
External Control Arms (ECA): Optimizing Submissions to HTA Agencies

16Jun

External Control Arms (ECA): Optimizing Submissions to HTA Agencies

by MarksMan Healthcare,  0 Comments

In the realm of pharmaceutical development, the pursuit of safe and effective treatments is paramount. To achieve this, rigorous clinical trials are conducted to evaluate the efficacy and safety of […]

Read More
Collaborative Approach In Systematic Literature Reviews For Evidence Synthesis

05Jun

Collaborative Approach in Conducting Systematic Literature Reviews For Evidence Synthesis

by MarksMan Healthcare,  0 Comments

A well-conducted systematic review and meta-analysis can be invaluable to help clinicians stay up-to-date on current evidence-based medicine.(1) However, systematic reviews and meta-analyses often tend to be highly focussed on […]

Read More

15May

The HARmonized Protocol Template to Enhance Reproducibility (HARPER) in RWE

by MarksMan Healthcare,  0 Comments

Real World Evidence (RWE) is generated as a result of the real-world usage of drugs, and thus can complement the RCT (randomized controlled trial) evidence that is generated in controlled […]

Read More

08May

Risk of Bias Assessment During Systematic Literature Reviews: Why and How?

by MarksMan Healthcare,  0 Comments

A systematic literature review (SLR) is considered the highest form of evidence due to its rigorous approach through which every relevant piece of published or unpublished literature that is currently […]

Read More

13Apr

Using ‘Limits’ While Developing SLR Search Strategy: Advantages and Disadvantages

by MarksMan Healthcare,  0 Comments

Systematic literature reviews (SLR) are a crucial tool to identify high-quality evidence for research, policy, and practice. The success of SLRs heavily relies on the performance of the literature search […]

Read More

10Apr

The Importance of CHARMS Checklist in the SLRs of Clinical Prediction Models

by MarksMan Healthcare,  0 Comments

Clinical prediction models (CPMs) are statistical models that use patient characteristics and clinical variables to estimate the probability of a particular health outcome, such as a disease or adverse event. […]

Read More

31Mar

The Role and Importance of SLRs and RWE in Drug Price Negotiations in the USA

by MarksMan Healthcare,  0 Comments

The cost of prescription drugs is a significant burden on patients and the healthcare system, especially in countries such as the USA. High drug prices can strain government programs, such […]

Read More

Posts navigation

1 2 3 4 … 15

Your Partner in Evidence
Synthesis and Market Access

Book Free Sampling Here

Latest Blogs

Quick links

Work with us

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Using Synthetic Controls in Oncology Real-World Data Studies for Treatment Insights

September 20, 2023

Strategizing Optimal Collection and Use of Real-World Data from Expanded Access Programs

September 18, 2023

International Reference Pricing vs. Value-Based Pricing: Drug Pricing Strategies

September 11, 2023

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

HEOR, RWE, and Market Access Consulting

  • J1309, Amethyst Tower, PBEL City, Peeramcheruvu, Rajendra Nagar Mandal, Hyderabad, Telangana – 500091
  • Call Us: +91-9160467576
  • enquiry@marksmanhealthcare.com

Latest Blogs

Using Synthetic Controls in Oncology Real-World Data Studies for Treatment Insights

September 20, 2023

Strategizing Optimal Collection and Use of Real-World Data from Expanded Access Programs

September 18, 2023

International Reference Pricing vs. Value-Based Pricing: Drug Pricing Strategies

September 11, 2023

Quick links

  • About Us
  • Our Services
  • Case Studies
  • Publications
  • Careers
  • Contact Us
  • Policy

Work with us

We believe that work is to be pursued and enjoyed through commitment, teamwork, creative thinking, and an ethical approach in everything we do. Apply HERE about openings

Copyright © 2023 Marksman Healthcare Communications Crafted by LUBUS

 

Loading Comments...